Article info
Review
Pragmatic guide to peripheral nerve disease and the role of clinical biomarkers
- Correspondence to Dr Michael P Lunn; michaellunn{at}nhs.net
Citation
Pragmatic guide to peripheral nerve disease and the role of clinical biomarkers
Publication history
- Accepted June 13, 2022
- First published July 18, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (18 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease
- Untangling a case of painful neuropathy
- Diagnosis and treatment in inflammatory neuropathies
- CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
- Peripheral nerve diseases
- CIDP: mimics and chameleons
- POEMS neuropathy: optimising diagnosis and management
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
- Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies
- Ultrasound in the diagnosis of peripheral neuropathy: structure meets function in the neuromuscular clinic